Overland Park, KS, United States of America

Kin-Kai Hwang

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kin-Kai Hwang. Retrieved from https://idiyas.com/inventor/kin-kai-hwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kin-Kai Hwang: Pharmaceutical Patent Inventor

Introduction

Kin-Kai Hwang is an inventor associated with Overland Park, Kansas, and Aventis Pharmaceuticals Inc. His patent work addresses the bioavailability of antihistamine medications.

Latest Patents

Hwang is credited with 1 patent, titled “Method of Enhancing Bioavailability of Fexofenadine and Its Derivatives.” The invention describes co-administering a piperidinoalkanol antihistamine with a p-glycoprotein inhibitor to enhance the antihistamine’s bioavailability in a patient.

Career Highlights

Hwang’s documented patent contribution focuses on pharmaceutical treatment and the potential role of p-glycoprotein inhibition in improving the availability of antihistamine compounds.

Collaborations

Hwang’s listed coworkers include Gail H. Hurst and Dennis Giesing. His patent is associated with Aventis Pharmaceuticals Inc.

Conclusion

Kin-Kai Hwang’s patent reflects an effort to improve the bioavailability of fexofenadine and related antihistamines through a combination approach.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…